These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16684088)

  • 1. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer.
    Supiot S; Bennouna J; Rio E; Meurette G; Bardet E; Buecher B; Dravet F; Le Neel JC; Douillard JY; Mahé MA; Lehur PA
    Colorectal Dis; 2006 Jun; 8(5):430-5. PubMed ID: 16684088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A; Georgiev R; Kurtev P; Kurteva G
    J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A; Parvanova V; Georgiev R; Gesheva N
    J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
    Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients].
    Gérard JP; Chapet O; Morignat E; Romestaing P; Mornex F; Acharki A
    Ann Chir; 1999; 53(10):1003-10. PubMed ID: 10670149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
    Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
    Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.
    Luna-Pérez P; Bustos-Cholico E; Alvarado I; Maffuz A; Rodríguez-Ramírez S; Gutiérrez de la Barrera M; Labastida S
    J Surg Oncol; 2005 Apr; 90(1):20-5. PubMed ID: 15786412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors affecting the prognosis and selection of local excision for low rectal cancer].
    Hang JW; Zhou ZX; Bu YQ; Bai XF; Wang X; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):141-3. PubMed ID: 17645854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
    Gunderson LL; Sargent DJ; Tepper JE; Wolmark N; O'Connell MJ; Begovic M; Allmer C; Colangelo L; Smalley SR; Haller DG; Martenson JA; Mayer RJ; Rich TA; Ajani JA; MacDonald JS; Willett CG; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1785-96. PubMed ID: 15067027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.